from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0853c/pdc

LFCtreatmentdescriptionclass of inhibitor

-1.099

Amikacinug/mL Amikacintranslation

-0.634

Cap5-10ug/mL Capreomycintranslation

-1.213

Rox10-50 ug/mL Roxithromycintranslation

-0.484

SM2-5 ug/mL Streptomycintranslation

-3.199

Tet5-10 ug/mL Tetracyclinetranslation

0.971

Rif0.2-5ug/mL Rifampicintranscription

0.345

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.167

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.728

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.951

CPZ10-50 ug/mL Chlorpromazinerespiration

1.480

Clofazimine10-13 ug/mL Clofaziminerespiration

0.539

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.214

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.911

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.247

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.126

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.037

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.539

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.890

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.346

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.534

KCN5-20 ug/mL Potassium cyaniderespiration

-1.069

NaN30.2-2 mM Sodium aziderespiration

0.747

Nigericin50 uM Nigericinrespiration

0.847

TRC10-150 ug/mL Triclosanrespiration

0.834

TRZ10-25 ug/mL Thioridazinerespiration

-1.195

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.190

menadione6-10 ug/mL Menadionerespiration

0.658

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.094

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.152

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.181

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.110

NRP_1Non-replicating persistence stage 1dosRassociated

-0.513

Amp0.2mg/mL AmpicillincellWall

-0.170

Cephalexin20-100 ug/mL CephalexincellWall

-0.357

Cerulenin0.32-5 ug/mL CerulenincellWall

1.358

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.281

EMB10-20 ug/mL EthambutolcellWall

-0.459

Eta12-40 ug/mL EthionamidecellWall

-0.555

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.567

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.549

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.115

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.551

BZA0.12 mg/mL BenzamidearomaticAmides

-0.401

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.370

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.240

H2O24 mM hydrogen peroxideDNAdamaging

-0.389

Levo10 ug/mL LevofloxacinDNAdamaging

-0.864

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.459

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.008

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.620

UVUV-irradiationDNAdamaging

0.951

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.233

Antimycin12.5-50 ug/mL Antimycin A?

-0.151

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.180

PA_110-50 ug/mL Antitubercular compound PA-1?

0.582

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.773

PA8240.2-2 ug/mL PA-824?

-0.370

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.188

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.282

Verapamil50 uM Verapamil?

0.201

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.339

methoxatin10-20 ug/mL Methoxatin?